Cannabis Growing Career

CORAL GABLES, FL / ACCESSWIRE / January 2, 2019 / The way people receive health care , including medical marijuana, is evolving. As public opinion surrounding cannabis becomes increasingly more favorable, the marijuana industry may begin to present an appealing opportunity for investors looking into the nascent sector. As experts and professionals in the field work to develop innovative approaches to developing products utilizing medicinal cannabis/hemp, the industry as a whole may benefit. Premier Health Group (PHGRF) (PHGI) , Aphria Inc (NYSE:APHA), Canopy Growth Corporation (NYSE:CGC) (TSX:WEED.TO), and Cronos Group Inc (NASDAQ:CRON) are 4 pot stocks worth looking into as the new year rolls onward.

Premier Health Group (PHGRF) (PHGI) has come into the limelight this past year as a result of the Company’s dedication to investing in the development of innovative, high tech treatment solutions for patients in the primary care space. Over the course of the past thirty days, Premier has seen a period of bullish trading as its shared climbed over 30% this past month.

Back in November, Premier Health Group (PHGRF) (PHGI) announced plans to expand the scope of its practice by launching a Cannabis Clinic for its patients. Recent reports indicate that the Company currently boasts an ecosystem of over 100,000 active patients in their network, with plans in the works to increase those numbers on a global scale.

Dr. Essam Hamza, Chief Executive Officer of Premier Health Group (PHGRF) (PHGI) said, “The role of Cannabis in treating medical conditions is continuously expanding. Our doctors have had success in treating their patients with various ailments from chronic pain to cancer-related symptoms. Unfortunately, there is a gap between the patient’s need for medical marijuana, and the family doctor’s comfort and knowledge to prescribe it. We are looking to fill that gap with various forms of clinics and services to help our patients and healthcare workers.”

For More Information On Premier Health Group, Click Here

Aphria, Inc (APHA) made headlines on Wednesday when it announced that its Columbiam subsidiary, Colcanna SAS had signed an exclusive agreement with the Federacion Medica Columbiana, a national entity that oversees the ethical exercise of medical professionals in Colombia, to collaborate on an academic curriculum on the medicinal use of cannabis.

Gabrial Meneses, Vice President, LATAM and Caribbean for Aphria, said, “Education in the medical community is critical for sustaining the advancement of medical cannabis in Colombia.Colcanna is proud to make this exclusive arrangement with Federación Medica Colombiana, which will offer doctors and medical professionals across the country a credible and trusted source of information and training on medical cannabis.”

For More Information On Aphria, Inc, Click Here

Canopy Growth Corporation (CGC) (WEED) announced, in early December, that it had entered into a multi-year extraction agreement with Valens GroWorks Corp, a licensed, vertically integrated provider of cannabis procured and services. Under the terms of the agreement, Valens will utilize their proprietary technology and methodologies to process the Company’s whole flower and trim into high-grade cannabis resin.

Mark Zekulin, President & Co-CEO, Canopy Growth, commented, “Diversifying our extraction supply capabilities with Valens, a company positioning itself as a specialized extractor, increases our ability to supply a consistent, high-quality inventory of oils for products such as Softgels. We’re also excited to see Valens progress in its licensing capabilities so that it can add its products to our CraftGrow program, increasing the diversity of high-quality cannabis products available for medical and recreational customers in 2019.”

For More Information on Canopy Growth Corporation, Click Here

Cronos Group Inc. (CRON) made headlines earlier this month when the Company announced it had entered into a subscription agreement with Altria Group, Inc. pursuant to which Altria agreed to make an approximately $2.4 billion equity investment in Cronos Group on a private placement basis in exchange for common shares in the capital of the Company.

In a press release regarding the matter, Cronos Group’s Mike Gorenstein, Chairman, President and Chief Executive Officer said, “Altria is the ideal partner for Cronos Group, providing the resources and expertise we need to meaningfully accelerate our strategic growth. The proceeds from Altria’s investment will enable us to more quickly expand our global infrastructure and distribution footprint, while also increasing investments in R&D and brands that resonate with our consumers. Importantly, Altria shares our vision of driving long-term value through innovation, and we look forward to continuing to differentiate in this area.”

For More Information On Cronos Group, Inc, Click Here

What Is Stock Price (

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for. was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (, you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns , may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns , may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information Please click here for full disclaimer .

Contact Information: